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Background: Although Transjugular Intrahepatic Portosystemic Shunts (TIPS) are effective 
procedures to alleviate portal hypertension [1], these artificial shunts are inherently prone to 
stenosis over time and therefore require monitoring [2]. Because direct portal pressure 
measurement is invasive and impractical for clinical follow-up, noninvasive monitoring measures 
have been attempted. Due to its anatomic relationship with the portal vein, spleen stiffness (SS), 
quantified via elastography, has been proposed as a noninvasive measure of TIPS function. 
Therefore, the objectives of this study were to: (a) review literature on SS as an acute measure of 
portal hypertension and shunt function in patients with TIPS, and (b) characterize the cohort of 
patients undergoing TIPS insertion at the University of Kansas Medical Center (KUMC) in 
anticipation of a prospective study at this institution. 
Methods: Through a systematic search of PubMed, five studies measuring SS before and after 
TIPS placement were identified and compared [3-7]. Data extracted from each study included: 
geographic location, number of subjects, subject characteristics, timing of elastography 
measurements, elastography exam technique, and findings. Additionally, the HERON 
(Healthcare Enterprise Repository for Ontological Narration) institutional database was used to 
generate a potential cohort of study subjects that included all adults who underwent TIPS 
insertion at KUMC from January 1, 2010 through September 27, 2016. CPT, ICD-9 and ICD-10 
diagnosis codes, vital status, and death date were selected using the HERON query tool. TIPS 
outcomes, including TIPS revision, liver transplantation, and mortality, were measured at six 
months, one year, two years, and beyond two years. 
Results: Four of the five studies found that splenic stiffness decreased after TIPS placement [3, 
4, 6, 7], while the fifth documented mixed results [5]. Timing of measurements, imaging 
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modalities, and embolization of collateral veins during TIPS placement differed among studies. 
The HERON search resulted in 298 patients for our cohort analysis – 59.1% were male, 85.2% 
were white, with an average of 56.3 years (SD±12.5). Within the follow-up period (range zero 
months to over five years), 30% (n=90) of patients underwent at least one TIPS revision, 16% 
(n=47) underwent liver transplantation, and 15% (n=46) died after TIPS placement. 
Conclusions: Reports of the utility of splenic elastography as an acute measure of portal 
hypertension in TIPS patients are promising, although somewhat conflicting. Discrepancies in 
study findings may be attributed to differences in patient characteristics, elastography technique 
and timing, or embolization of collateral veins. A larger, prospective study is warranted, as 
elastography has the potential to be a safe, noninvasive, cost-effective measure of TIPS function. 
Because KUMC performs a substantial number of TIPS procedures in a diverse patient 
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Chapter I: Introduction 
 The Transjugular Intrahepatic Portosystemic Shunt (TIPS) is an effective procedure to 
alleviate portal hypertension [1]. By creating an artificial pathway from the portal to the hepatic 
vein, TIPS allows blood from the congested portal circulation to bypass the fibrotic liver and 
directly enter the systemic circulation [1]. Unfortunately, TIPS are inherently prone to stenosis or 
complete occlusion over time, and thus require frequent monitoring [2]. Direct measurement of 
the Hepatic Venous Pressure Gradient (HVPG) is the gold standard for quantifying portal 
hypertension and shunt patency. However, HVPG is an invasive test requiring central venous 
access and iodinated contrast material, making it an impractical method for frequent clinical 
follow-up [8]. For this reason, noninvasive measures of portal hypertension in patients with TIPS 
have been attempted. One noninvasive measure, elastography, is an imaging modality that 
quantifies tissue stiffness. Due to its anatomic relationship with the portal vein, splenic stiffness 
(SS), measured via elastography, has been proposed as noninvasive measure of TIPS function.  
 Current clinical follow-up for TIPS patients uses periodic Doppler ultrasound studies to 
monitor for early hemodynamic changes [9]. However, Doppler exams for TIPS are operator-
dependent, and their use is inconsistent in clinical practice [9]. Additionally, the accuracy of 
Doppler measurements for TIPS can be greatly affected by patient respiration during the exam 
[10]. Measurements of flow velocities are also limited by depth of the vessel of interest from the 
body surface, which can be greatly increased by large patient body habitus and presence of 
ascites [9]. Moreover, Doppler parameters were established in the 1990s [11] and have not been 
updated since the transition from the use of bare metal to covered stents in TIPS procedures [2]. 
Furthermore, venous hemodynamics in patients with TIPS are complex, as collateral circulation 
may develop uniquely in each patient [12, 13]. Thus, portal circulation velocities may not 
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accurately approximate TIPS function. Reports of the sensitivity of Doppler parameters in 
detecting TIPS dysfunction range from 33-93% [9]. 
 A potential complement to Doppler exams is elastography measurement of SS. 
Elastography is a medical imaging modality that can map and/or quantify tissue stiffness [14]. 
There are several forms of elastography, including Acoustic Radiation Force Impulse imaging 
(ARFI, also commonly referred to as shear wave elastography) and Magnetic Resonance 
Elastography (MRE). ARFI is a form of ultrasound elastography that sends acoustic waves into 
the body and measures the velocity of the resulting shear wave to determine the stiffness of the 
tissue sampled [14]. Similarly, MRE uses magnetic resonance imaging to measure the 
propagation of shear waves generated after a mechanical impulse is delivered to the area of 
interest [14]. 
 Several studies have shown that SS, measured via elastography, is directly correlated to 
HVPG [15, 16]. Since the splenic vein drains into the portal vein, increased portal pressure 
results in splenic congestion, which is reflected by increased SS [15, 16]. However, these studies 
measured SS and HVPG at one point in time [15, 16]. What is not known is whether an acute 
change in portal pressure, such as after TIPS placement, is reflected by a corresponding change 
in SS. Therefore, the primary purpose of this study is to review the current literature on how SS 
changes after portal pressure is reduced during TIPS placement. If there is a measureable 
decrease in SS after TIPS placement, elastography of the spleen may be an accurate acute 
measure of portal hypertension, and therefore, a non-invasive measure of shunt function in the 
clinical follow-up of TIPS patients. Accurately diagnosing shunt malfunction would increase the 
opportunity for early intervention before symptomatic shunt failure. The secondary purpose of 
this study is to characterize the cohort of patients undergoing TIPS placement at the University 
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of Kansas Medical Center (KUMC), a regional liver transplant center, in support of conducting a 
prospective study at this institution.  
Chapter II: Methods 
Review of the Literature 
 We conducted a search in the electronic database PubMed on February 23, 2017 using 
key words indexed by Medical Subject Headings (MeSH). We used MeSH to generate the 
following search: “(("Elasticity Imaging Techniques"[Mesh] OR elastography OR shear wave 
elastography OR transient elastography)) AND (("Spleen"[Mesh]) AND (("Hypertension, 
Portal"[Mesh]) OR "Portosystemic Shunt, Transjugular Intrahepatic"[Mesh])).” We searched 
only for studies published since 2010 because the first commercially available machines capable 
of performing imaging-based elastography became available in the late 2000s [14]. Prior to that 
time, imaging-based elastography was available at limited institutions for research purposes only 
[14]. After limiting our search results to publications in the English language, 62 potential 
studies were reviewed. Upon discovering that many of the studies in our search results were not 
specific to TIPS patients, we narrowed our search to “elastography AND spleen AND 
transjugular intrahepatic portosystemic shunt,” which yielded six papers. Studies were selected 
for inclusion if they obtained elastography measurements of SS before and after the TIPS 
procedure. A total of five studies were included in the final literature review. A diagram of 
literature searches and study inclusion is depicted in Figure 1. 
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Figure 1: Literature Search Flow Diagram 
A template was created for data extraction from each study. Data items included: study 
geographic location; number of subjects; subject characteristics, such as gender, age, etiology of 
cirrhosis, and indication for TIPS placement; timing of elastography measurements in relation to 
TIPS placement; elastography exam technique; and elastography exam results.  
Characterization of the TIPS Patient Population at KUMC 
 We used the HERON (Healthcare Enterprise Repository for Ontological Narration) 
institutional database to generate a cohort of potential study patients at KUMC by using the i2b2 
(Informatics for Integrating Biology and the Bedside) query tool with specific diagnosis and 
procedural codes. HERON is an integrated data repository that utilizes electronic medical 
records, billing systems, and cancer registries at KUMC [17]. All adult patients who underwent 
TIPS placement at KUMC between January 1, 2010 and September 27, 2016 were initially 
included in the search. We selected January 2010 as our start date because that is when KUMC 
transitioned to electronic medical records. Current Procedural Terminology (CPT) codes for 
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TIPS placement and revision, as well as liver transplantation, were selected in the i2b2 system. 
Additionally, select International Classification of Diseases (ICD-9 and ICD-10) diagnosis codes 
were pulled to estimate the etiology of each patient’s liver disease. Vital status and date of death, 
if available, were also selected.  
 De-identified records were collected and managed using REDCap electronic data capture 
tools hosted at KUMC [18]. SQLite and SAS 9.4 were used to analyze the data. Date of initial 
TIPS placement was used at the baseline time point for all temporal analyses. Patients were 
excluded if they were denoted as deceased with an unknown death date (n=11), underwent liver 
transplantation before TIPS placement (n=11), or underwent TIPS revision before initial 
placement (n=2). After exclusion, our final analysis included 298 patients. A study flow diagram 
is depicted in Figure 2. 
 
Figure 2: HERON Study Flow Diagram 
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Etiology of patients’ liver disease was attributed to select diagnoses that were recorded 
before, or within 30 days after, initial TIPS placement. For the purpose of comparing outcomes 
based on etiology of liver disease, patients were divided into two etiologic groups: Alcohol and 
Other. Patients were considered to have cirrhosis due to alcohol if they had an ICD-9 or ICD-10 
code denoting alcoholic liver disease (diagnostic group “Alcohol”). All patients without a 
relevant diagnosis code indicating alcoholic cirrhosis were considered to have cirrhosis due to 
another cause (diagnostic group “Other”). The diagnostic group “Other” included both patients 
with a diagnosis code for an etiology of liver disease other than alcoholic cirrhosis, and patients 
without any of the diagnostic codes selected. 
Chapter III: Results 
Review of the Literature 
 
 A total of five studies measuring SS before and after TIPS placement met inclusion 
criteria. A summary of each study is included in Table 1. Four studies utilized ARFI [3-6] while 
one used MRE [7]. Four studies found that SS decreased after TIPS placement [3, 4, 6, 7]. The 
fifth study found that splenic stiffness decreased in 58% (11 of 19) participants, but increased in 
42% (8 of 19) following TIPS placement [5]. 
 Three studies were conducted by the same research group in Chongqing, China (Gao and 
Ran et al.) in patients who had a history of cirrhosis secondary to Hepatitis B virus (HBV) 
infection and a history of bleeding gastroesophageal varices [3, 4, 6]. In those three studies, 
ARFI measurements of SS were taken one day before and 3-10 days after TIPS placement in 
fasting patients[3, 4, 6]. All three studies found a significant decrease in SS after TIPS 
placement. The 2012 study of 10 TIPS patients found that SS decreased from 3.65 (SD±0.32) 
pre-TIPS to 3.27 (SD±0.30) post-TIPS placement (p<0.001). The 2013 study of 12 TIPS patients 
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found that SS decreased from 3.50 (SD±0.46) pre-TIPS to 3.15 (SD±0.39) post-TIPS placement 
(p=0.00015). Finally, the 2016 study found that SS decreased from 3.64 (SD±0.23) pre-TIPS to 
3.18 (SD±0.21) post-TIPS placement (p=0.0002). 
 Similarly, Guo et al. conducted a study of 10 TIPS patients in Berlin, Germany using 
MRE to measure SS one day before and 2-3 days after TIPS placement [7]. The study does not 
mention the etiology of liver disease in the subjects, nor does it comment on patient fasting 
status. In congruency with the results of the three previously mentioned studies conducted by 
Gao and Ran [3, 4, 6], Guo et al. observed a significant decrease in SS after TIPS (pre-TIPS SS: 
8.44 ± 1.36 kPa, post-TIPS SS: 7.06 ± 1.32 kPa, p=0.01). 
 Finally, a fifth study at the University of Michigan by Novelli et al. utilized ARFI to 
measure SS in 19 TIPS patients within one hour before, and immediately after, the TIPS 
procedure [5]. They also measured SS on post-operative day one in all patients, and on each 
subsequent day that the patient remained hospitalized after the TIPS procedure, up to day three. 
Though not explicitly stated, it can be inferred that patients were fasting for elastography 
measurements of SS obtained immediately before and after TIPS placement, as patients are 
required to fast for this surgical procedure [1]. However, the study authors do mention that 
exams on subsequent days of hospitalization (days 1-3) were obtained in a non-fasting state.  In 
contrast to the studies by Gao and Ran et al. in which all patients had cirrhosis secondary to 
HBV [3, 4, 6], patients in this study had varying etiologies of cirrhosis. Causes of liver disease 
reported include alcohol, Hepatitis C virus (HCV), nonalcoholic steatohepatitis (NASH), 
cryptogenic, and other. In contrast to all previously discussed studies, this study did not report a 
significant decrease in SS after TIPS placement. While SS decreased in 58% (11/19) of patients, 
SS increased in 42% (8/19) of patients. Novelli et al. mention that patients with portosystemic 
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collateral veins embolized during the TIPS procedure were more likely to demonstrate increased 
splenic stiffness after TIPS placement than those who did not undergo collateral embolization 






















Table 1: Study Characteristics 
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Characterization of the TIPS Patient Population at KUMC 
 A total of 298 patients were included in this analysis. The cohort was 59.1% male, 85.2% 
white, and had a mean (SD) age at TIPS insertion of 56.3 (12.5) years. Patient characteristics are 
displayed in Table 2. 
Table 2: Patient Demographics 
Characteristic Value 
Mean age, years (SD) 56.3 (12.5) 
Gender, n (%) 
      Male 
      Female 





Race, n (%) 
      White 
      African-American 
      Asian 






Language, n (%) 
      English 
      Spanish 





Diagnosis, n (%)a 
      Alcoholic cirrhosis 
      AIH 
      HBV 
      HCV 
      NAFLD/NASH 
      PBC 









Number of diagnoses, n (%)b 
      0 
      1 
      2 
      3 







a Percentages for diagnoses do not add up to 100% as some 
patients had none or multiple of the diagnoses listed. AIH = 
Autoimmune hepatitis; HBV = Hepatitis B Virus; HCV = 
Hepatitis C Virus; NAFLD = Nonalcoholic Fatty Liver Disease, 
NASH = Nonalcoholic Steatohepatitis; PBC = Primary Biliary 
Cirrhosis; PSC = Primary Sclerosing Cholangitis 
b Indicates the number of selected diagnoses a given patient had 
in his or her medical record. 
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 Patient outcomes are displayed in Table 3. Thirty percent (n=90) of patients underwent at 
least one TIPS revision procedure. Seventeen percent (n=51) underwent revision within six 
months post-TIPS placement, 22% (n=66) within one year, and 27% (n=79) within two years. 
Sixteen percent (n=47) of patients underwent liver transplantation after TIPS insertion, with 7% 
(n=21) receiving a transplant six months post-TIPS, 10% (n=30) within one year, and 14% 
(n=42) within two years. Twenty-eight percent (n=82) of patients died after TIPS placement, 
with 15% (n=46) of patients dying within six months post-TIPS, 21% (n=62) within one year 
and 24% (n=72) within two years.  
Table 3: Outcomes for TIPS patients at KUMC 






By 6 months 51 (56.7%)  21 (44.7%) 46 (56.1%) 
By 1 year 66 (73.3%) 30 (63.8%) 62 (75.6%) 
By 2 years 79 (87.8%) 42 (89.4%) 72 (87.8%) 
Beyond 2 years 90 (100%) 47 (100%) 82 (100%) 
Note: numbers above are cumulative. For example, the number of patients having undergone a 
TIPS revision by 1 year includes those patients who underwent a revision by six months. 
Percentages reflect the proportion of total patients who experienced the given outcome by the 
specified time point. 
 
We compared the incidence of the above outcomes (TIPS revision, liver transplant, 
death) in patients with and without a diagnosis of alcoholic liver disease. Patients with alcoholic 
liver disease were not significantly more or less likely to undergo TIPS revision [OR=1.23; 95% 
CI (0.77, 2.07);], receive a liver transplant [OR=0.72, 95% CI (0.39, 1.36)], or die [OR=0.97, 
95% CI (0.58, 1.61)] during the follow-up period than patients with cirrhosis due to a cause other 
than alcoholic liver disease. These results are displayed in Table 4. 
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Table 4: Outcomes by Diagnosis: Alcohol vs. Other 
 Odds Ratio 95% Confidence Interval 
Revision 1.3 (0.8, 2.1) 
Transplant 0.72 (0.4, 1.4) 
Mortality 1.0 (0.6, 1.6) 
 
Chapter IV: Discussion 
Review of the Literature 
In this systematic literature review, we found five published studies measuring SS via 
elastography before and after TIPS placement. Three studies were conducted by the same 
research group in China [3, 4, 6], while another was conducted in Germany [7], and one in the 
United States [5]. Four studies utilized ARFI [3-6], while one used MRE [7], to measure SS. 
Four of the five studies found a significant decrease in SS after TIPS placement [3, 4, 6, 7], while 
a fifth study found inconclusive results [5]. Differences in study findings could be attributed to 
timing of measurements with respect to the TIPS procedure, elastography imaging modality and 
techniques, patient baseline characteristics, and/or embolization of collateral veins. 
 One possible explanation for the discrepancy in study findings is the timing of 
elastography measurements. All four studies that found a significant decrease in SS after TIPS 
took post-TIPS SS measurements between three and twelve days after the procedure [3, 4, 6]. 
The study by Novelli et al., which found that SS increased in 42% (8/19) of patients, took post-
TIPS SS measurements immediately following the procedure [5]. It may be that the correlation 
between HVPG and SS [16] is simply a reflection of congestion of the spleen with venous blood. 
However, it is also possible that increased SS in the setting of portal hypertension is additionally 
attributable to some degree of fibrosis in response to venous congestion [19, 20]. If increased SS 
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in the setting of increased HVPG is solely due to venous congestion, then a change in SS should 
be immediately detectable following the relief of venous congestion associated with TIPS 
placement. On the other hand, fibrotic changes would take longer to correct. It is possible that 
Novelli et al.’s mixed findings could be attributable to the fact that their measurements were 
obtained immediately after the procedure, when changes due to vascular congestion should be 
detectable, but fibrotic and architectural changes may not. 
 Another possible explanation for the discrepancy in study findings may be differences in 
imaging modalities. While four of the five studies used ARFI [3-6], one used MRE [7]. To our 
knowledge, no studies have been done comparing MRE and ARFI in the spleen, as elastography 
of the spleen is not widely performed. However, elastography is commonly used in measurement 
of hepatic fibrosis and staging of cirrhosis [21]. Yoon et al. conducted a study comparing MRE 
and ARFI measurements of liver stiffness in 75 patients [22]. Authors found no difference in 
technical success rates between the two elastography modalities in the liver, but did find that 
ultrasound-based shear wave elastography resulted in less reliable measurements [22]. 
Additionally, this study observed a moderate correlation between MRE and ARFI measurements 
(r=0.724, p<0.001). Though not directly applicable to the spleen, this study by Yoon et al. 
demonstrates that there is moderate correlation between MRE and ARFI measurements of tissue 
stiffness in the liver, and MRE exams may be more reliable than elastography measurements 
obtained via ultrasound.  
 In addition to imaging modality used to obtain elastography measurements, exam 
technique may have contributed to the variability in findings across studies. Elastography exams 
are most accurately performed during patient breath-hold [16]. In the studies by Gao and Ran et 
al. [3, 4, 6] authors deferred post-TIPS SS measurements to several days after the procedure as 
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“patients could not tolerate the exam” immediately post-operation. However, it is uncertain 
exactly why patients could not tolerate the exam, as the authors do not elaborate further. We 
postulate that the patients’ difficulty tolerating the exams could be attributable to post-operative 
pain, or the type of sedation used during the procedure. On the other hand, Novelli et al. 
performed post-TIPS SS exams “immediately following the procedure.” Authors did not mention 
the patient’s ability to hold his or her breath or to tolerate the exam. However, it is possible that 
patients in this study by Novelli et al. were not able to perform optimal breath-hold during the 
examination, which could have affected measurements of SS. 
 An additional factor that may affect the accuracy of elastography measurements is 
patients’ fasting status. After a meal, blood flow to the portal circulation is increased, which 
could falsely inflate SS measurements. Although Gao and Ran et al. state that patients were 
fasting for all elastography exams [3, 4, 6], the study by Guo et al. does not comment on patient 
fasting status [7]. Though not explicitly stated, patients in the study by Novelli et al. can be 
presumed to have been fasting for measurements immediately before and after TIPS placement, 
as patients are required to fast in preparation for this surgical procedure. However, Novelli et al. 
do explicitly state that patients were not fasting for exams on subsequent days of 
hospitalizations. Therefore, it is possible that Novelli et al. performed post-TIPS SS 
measurements too soon after TIPS placement to detect a meaningful decrease in SS. It is possible 
that this study may have detected a decrease in SS by post-operative days one through three had 
patients been fasting for these exams. 
 Another potential factor that could explain the differences in study findings is patient 
baseline characteristics, such as etiology of liver disease. In all three studies performed in China, 
all patients included had cirrhosis induced by HBV [3, 4, 6]. In contrast, patients in the US study 
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had varying etiologies of liver disease, including alcohol, NASH, and HCV [5]. Guo et al. do not 
comment on the etiology of liver disease in their patients [7]. Due to differences in patient 
baseline characteristics, these studies may not be directly comparable. It is not known how 
various causes of cirrhosis may affect portal circulation, and therefore SS. However, it is 
possible that the cause of a patient’s liver disease could affect these measurements. 
 Yet another potential explanation for the discrepancy in findings between studies is the 
embolization of collateral veins during the TIPS procedure. Because collateral circulation may 
develop in patients with cirrhosis [12, 13], physicians performing TIPS procedures may look for 
collateral veins that have developed to facilitate blood bypassing the fibrotic liver and created 
“competitive shunts.” Some physicians embolize these collateral veins so they are not competing 
with the newly-formed TIPS for blood flow. Novelli et al. note that patients who underwent 
embolization of collateral veins during TIPS placement were significantly more likely to show 
an increase in SS after TIPS. However, not all 8 of the 19 patients in this study with increased SS 
after TIPS underwent collateral vein embolization, so this factor alone cannot fully explain the 
surprising finding of increased SS in some patients after TIPS placement. Interestingly, though 
Novelli et al. comment heavily on embolization of collateral veins during the TIPS procedure, 
this strategy is not mentioned by any other studies in this review. Therefore, it is unknown if this 
procedure took place in, or contributed to the results of, the other studies. 
 A limitation of this systematic review is that there is potential for bias across studies, 
particularly since the same group of investigators published three of the five studies [3, 4, 6]. 
Initially this evoked a concern for patient overlap between these three studies. However, each 
study lists the date ranges in which patients were recruited, and they do not overlap between the 
three studies by Gao and Ran et al., reducing the concern for patient overlap. There is also a 
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potential for publication bias. It is possible that more studies assessing elastography of the spleen 
before and after TIPS have been performed but not published, particularly if they found no 
significant decrease in SS after TIPS placement. 
Characterization of the TIPS Patient Population at KUMC 
 Utilizing the HERON institutional database, we characterized the cohort of patients who 
underwent TIPS placement at our institution over a six and a half year period. We found that our 
TIPS patient population is diverse with respect to age, gender, and etiology of liver disease. We 
also found that 30% of our TIPS patients undergo at least one TIPS revision, and about 16% 
receive a liver transplant after having a TIPS. This supports the need for a more accurate tool to 
support clinical follow-up of TIPS function. 
 A potential limitation of this cohort analysis is that HERON is an institution-specific 
database, meaning that follow-up data is only present when patients receive follow-up care at our 
institution. One advantage to studying this specific population at KUMC is that we are a regional 
liver transplant center, and one could argue that patients with liver disease are more likely to 
continue follow-up here than elsewhere in the area. Another possible limitation of this analysis is 
the length of opportunity for follow-up. Patients undergoing TIPS near the end of the specified 
date range in the query (say, September 2016) would have less opportunity for follow-up than 
patients undergoing TIPS placement early in the specified date range (January 2010), which 
could skew outcomes results. 
Conclusion  
  
Elastography of the spleen has the potential to be an accurate acute measure of portal 
hypertension in patients with TIPS. Based on the results of our systematic review of the 
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literature, the data supporting its potential are promising, yet somewhat conflicting. Additionally, 
all studies performed on this application of elastography have been small, ranging from just 10-
33 patients. Furthermore, most studies on this topic have been performed in Asia and Europe, 
with only one study in the United States. Therefore, a larger, prospective study is warranted, 
particularly one applicable to the US population of patients with cirrhosis.  
 KUMC is a regional liver transplant center, performing a high volume of TIPS 
procedures. The population of patients undergoing TIPS placement at KUMC is diverse with 
respect to age, gender, and etiology of liver disease, making KUMC an ideal site for a future 
study. This future study would contribute valuable data to support or refute the use of SS to 
measure TIPS function. More accurate monitoring of TIPS patients could significantly reduce 
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